Mu-opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine

Christopher P Bailey1, Daniel Couch, Elizabeth Johnson

  • 1Department of Pharmacology, University of Bristol, School of Medical Sciences, Bristol BS8 1TD, United Kingdom. chris.bailey@bris.ac.uk

Insights

Morphine poorly desensitizes mu-opioid receptors (MORs). Unlike DAMGO and methadone, morphine does not cause significant MOR internalization, even when combined with DAMGO, challenging previous theories.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Mu-opioid receptors (MORs) are crucial targets for pain management.
  • Opioid agonists typically induce MOR desensitization and internalization.
  • Morphine's limited effect on MOR desensitization has been inconsistently reported.

Purpose of the Study:

  • To investigate the differential desensitization and internalization effects of morphine, DAMGO, and methadone on MORs.
  • To examine the proposed synergistic effect of DAMGO in enhancing morphine-induced MOR internalization.

Main Methods:

  • Electrophysiological recordings in mature rat locus ceruleus (LC) neurons.
  • Measurement of plasma membrane receptor levels in HEK293 cells expressing rat MOR1.
  • Assessment of MOR desensitization and internalization in response to various opioid agonists and coapplications.

Main Results:

  • Morphine demonstrated poor MOR desensitization in LC neurons, unlike DAMGO and methadone.
  • DAMGO and methadone, but not morphine, induced rapid MOR internalization in HEK293-MOR1 cells.
  • Coapplication of low DAMGO concentrations with morphine did not enhance morphine-induced MOR desensitization or internalization in neurons or cell lines.

Conclusions:

  • Morphine is a weak inducer of MOR desensitization and internalization compared to DAMGO and methadone.
  • The theory that low DAMGO concentrations enhance morphine-induced MOR internalization is not supported by these findings.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...